Results of Single Center Study on Delcath's CHEMOSAT® Hepatic Delivery System Published in Melanoma Research
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
📰 Solid Tumors News
Page 50 - Solid Tumors News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Solid Tumors. Real-time updates on events, politics, business and more.
Brainomix Announces New Partnership with Boehringer Ingelheim to Develop AI-Powered Radiomic Software for Automated Assessment of Solid Tumor Cancer
The collaboration will focus on the development of AI tools to improve the accuracy and standardization of tumor measurement in lung cancer trials OXFORD, England, Feb. 1, 2022 /PRNewswire/
Prnewswire Brainomix Boehringer Ingelheim Eric Greveson Florian Gantner University Of Oxford Drug Administration
Source: finanznachrichten.de
Deciphera Pharmaceuticals Presents Results from the INTRIGUE Phase 3 Clinical Study at the American Society of Clinical Oncology Plenary Series Session
– Efficacy Observed with QINLOCK® was Comparable to Sunitinib with a More Favorable Safety and Tolerability Profile in GIST Patients Previously Treated with Imatinib – ... | January 24, 2022
United States Hong Kong United Kingdom Vicki Keedy Michael Heinrich Vanderbilt University Medical Center
Source: marketscreener.com
Deciphera Pharmaceuticals Pres - GuruFocus.com
GuruFocus Article or News written by Business Wire and the topic is about:
United States Hong Kong United Kingdom Vicki Keedy Michael Heinrich Vanderbilt University Medical Center
Source: gurufocus.com
CT radiomics, machine learning predict melanoma survival
The combination of CT radiomics and machine learning can predict survival of melanoma patients after immunotherapy better than relying only on tumor size.
Laurent Dercle David Mankoff Michael Farwell University Of Pennsylvania Columbia University Medical Center Response Evaluation Criteria
Source: auntminnie.com
Oncology Based In-Vivo Contract Research Organization (CRO) Market Size, Share, Trends, Outlook, Fut
Oncology Based In-Vivo Contract Research Organization (CRO) Market report contains market data that can be relatively essential when it comes to dominate the healthcare industry or make a mark in the market as a new emergent. It also deliberately analyses the growth trends and future prospects. This wide-ranging mar...
Source: pharmiweb.com
Poseida Therapeutics Announces Eric Ostertag to Serve as Executive Chairman and Transition Role of CEO to Current President and CBO Mark Gergen
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform...
Source: prnewswire.com
Poseida Therapeutics Announces Eric Ostertag to Serve as Executive Chairman and Transition Role of CEO to Current President and CBO Mark Gergen
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
China NMPA Approves Tislelizumab as Second- or Third-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
China NMPA Approves Tislelizumab as Second- or Third-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Research Report 2021: Analysis of Yescarta, Tecartus, Kymriah, Breyanzi, & Abecma
/PRNewswire/ -- The "Current Research & Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy" report has been added to ResearchAndMarkets.coms...
United States Laura Wood Barriers To Research Company Specific Intellectual Property Formula Pharmaceuticals Inc Gilead Sciences Inc
Source: prnewswire.com